About Jack Lasersohn
Jack Lasersohn is a director at Route 92 Medical.
Jack Lasersohn reports to the SEC as a director or major shareholder of 6 public companies, including Silk Road Medical (SILK), OncoMed Pharmaceuticals (OMED) and Masimo (MASI).
Jack Lasersohn first appears on SEC filings in 2006.
Experience
This experience comes from SEC filings. The years are when the filings name Jack Lasersohn in the role, so the role may have started earlier or lasted longer.
Route 92 Medical, Inc.
Director
2016 – 2026 · West Jordan, UT
Catheters for clinicians treating stroke and other conditions affecting blood vessels in the brain.
SI
Silk Road Medical Inc
Director
2019 – 2024 · Public company (SILK)
OI
OncoMed Pharmaceuticals Inc
Director and 10% owner
2013 – 2019 · Public company (OMED)
MC
Masimo Corp.
Director
2007 – 2015 · Public company (MASI)
YI
YIELD10 Bioscience, Inc.
Director and 10% owner
2006 – 2008 · Public company (YTEN)
KI
Kyphon Inc.
Director
2006 – 2007 · Public company (KYPH)
AC
Alsius Corp
Director
2007 · Public company (ALUS)
Key Colleagues at Startups
The people Jack Lasersohn works with at each company, as listed on that company's latest Form D.
Route 92 Medical, Inc. · Form D, Apr 20, 2026
Tony Chou
Founder, Chief Executive Officer and director
AG
Ariella Golomb
Director
John Miller
Chief Technology Officer
NJ
Noel Jee
Director
JR
Jonathan Root
Director
JM
J. Mackin
Director
MH
Mitchell Hill
Director
Cindy Lynch
SVP, Legal Affairs
LB
Lucas Buchanan
Director
Randall Sullivan
SVP, Operations
KV
Kirsten Valley
Executive officer
Chris Hartman
Chief Commercial Officer
CC
Casper de Clercq
Director